Why the study?
Does obesity, with or without metabolic syndrome, impair preclinical systolic and diastolic function compared to nonobese controls?
Population
190 individuals without cardiac disease, including obese individuals with metabolic syndrome, obese…
Comparison
Obesity with or without metabolic syndrome vs Nonobese controls
Design
Cross-sectional
Authors
Loading...
Obesity may impair LV function even without metabolic syndrome; leaves open whether metabolic health modifies HF risk or progression.
Does obesity, with or without metabolic syndrome, impair preclinical systolic and diastolic function compared to nonobese controls?
Obesity is associated with subclinical systolic and diastolic dysfunction regardless of metabolic syndrome status, suggesting obesity itself has adverse cardiovascular effects.
Wang et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: